This is the FIRST live streamed only, three day professional conference discussing Cellular Therapies. We have gathered together invited speakers from around the world, who you might not otherwise have access to.
Abstracts for poster presentation only can be submitted up to 2nd September 2016
The Deadline for abstract submissions for oral presentation is 30th August 2016
From basic research to clinical practice, this multi-disciplinary event provides an opportunity to share and compare research progress and clinical experiences to establish reliable cellular therapies.
Who Should Attend: Anyone with an interest in cellular therapies, stem cell transplantation or regenerative medicine will find this event useful. Our events are multi-disciplinary and our delegates include academic researchers, clinicians and people from the pharmaceutical industry.
We encourage questions, discussion and debate and have a relaxed atmosphere which generates maximum interaction online.
After registration you will be connected to an online networking site where you will be able to have discussions with all participants of this event, before, during and after the meeting.
The event will be recorded and available for all registered delegates up to a month after the event. So if you can’t manage all the days, or the different time zones, you can still have access to the full event.
Invited speakers and their talks include:
Talk
Speaker
Affiliation
Country
Why Cell Therapy Needs an Extracellular Matrix: Hydrogels for the Clinic
Professor Glenn D. Prestwich
The University of Utah
United States
Hemopoietic Stem Cell Transplantation in the Era of Personalized Medicine
Dr Arnold Ganser
Hannover Medical School
Germany
ErbB retargeted CAR T-cell immunotherapy of head and neck cancer
Dr John Maher
King's College Hospital
London, United
Experimental and clinical airway restoration by mesenchymal stromal cell endoscopic transplantation
Dr Francesco Petrella
Istituto Europeo di Oncologia
Italy
A Novel Method for Deriving Neuronal Progenitors for Parkinson’s Disease Therapy
Associate Professor Yiling Hong
Western University of Health Sciences
United States
The fate of intravenously injected mesenchymal stromal/stem cells
Dr. Reinhard Henschler
Blood Center Zurich
Switzerland
Stem Cell Therapies: A Regulatory Scientific Approach for Successful Translation into the Clinic
Dr Houria Bachtarzi
ERA Consulting (UK) Ltd
United Kingdom
Vector manufacturing for stem cell and other cell therapy purposes
Dr. Klaus Kühlcke
EUFETS GmbH
Germany
The role of the immune system in enhancing the homing and engraftment of stem cells to the heart after myocardial infarction: Potential therapeutic targets for regenerative therapy
Professor Ahmed Abdel-Latif
University of Kentucky
United States
Talk title to be confirmed
Dr. Oliver Pullig
Fraunhofer-Institute Interfacial Engineering and Biotechnology
Germany
Restoring immune competence after allogeneic stem cell transplantation: A double edged sword
Dr Martin Guimond
Maisonneuve-Rosemont Hospital
Canada
Talk title to be confirmed
Omar El-Shaarawy
.
Egypt
Towards optimising the use of umbilical cord blood for immunotherapy
Dr Aurore Saudemont
Anthony Nolan
United Kingdom
Talk title to be confirmed
Dr. Jo-Anna Reems
University of Utah School of Medicine
United States
The leukaemic stem cell niche and its possible therapeutic targeting
Professor Daniela Krause
Georg-Speyer-Haus
Germany
Sex, stem cells and regenerative medicine
Dr. Kirsten McEwen
Imperial College London
United Kingdom
CXCR4 knockdown in hematopoietic stem cells as a cure strategy for WHIM syndrome immunodeficiency
Dr. Philip M. Murphy
National Institute of Allergy and Infectious Diseases
United States
Immune-senescence and immune-exhaustion in hematopoietic stem cell transplantation and adoptive immunotherapy
Dr. Federico Simonetta
University of Geneva
Switzerland
Talk title to be confirmed
Dr. Sohel Talib
California Institute for Regenerative Medicine
United States
Human amniocytes as a countermeasure to osteopenia in a mouse model of fragile bones.
Dr. Pascale V Guillot
University College London
United Kingdom
Talk title to be confirmed
Professor Hala Gali-Muhtasib
American University of Beirut
Lebanon
Adipose-derived stem cell seeded biominerizable nanocomposite for chest wall repair: suppression of inflammatory response in a murine model
Dr. Johanna Buschmann
University Hospital Zurich
Switzerland
Functionalized carbon nanotubes in the ex vivo expansion of hematopoietic stem & progenitor cells
Associate Professor and Assistant Head Gigi Chiu Ngar Chee
National University of Singapore
Singapore
A holistic approach to MSC culture process design
Dr. Karen Coopman
Loughborough University
United Kingdom
A Euroscicon live streamed event gives you access to a wider range of international speakers at a fraction of the cost of a real world event. Furthermore, you no longer have to worry about travel or accommodation expenses, or any arrangements you have which clash with our events.
Moving Forward with Stem Cell Therapy has an open abstract session:
Abstracts can be submitted on any subject related to Stem cell biology or Stem cell or Cellular therapies
Advisory Board Members
Member
Affiliation
Country
Dr. Daniel Peterson
Rosalind Franklin University of Medicine and Science
United States
Dr Cornelia Kasper
University of Natural Resources and Life
Austria
CPD Credits
Credits from The Institute of Biomedical Science (code)
Approved by the Royal Society of Biology for purposes of CPD
18(MS010N16)
This event may be counted as 54 CPD credits